BCI

Neurovalens Achieves FDA Clearance for Anxiety Treatment Device

Neurovalens Achieves FDA Clearance for Anxiety Treatment Device

Neurovalens Receives FDA Clearance for Anxiety Treatment Device Neurovalens, a pioneering health technology company headquartered in Belfast, Northern Ireland, has recently achieved a significant milestone with the receipt of regulatory clearance from the US Food and Drug Administration (FDA) for its groundbreaking Modius Stress device. This innovative device is specifically engineered to address anxiety, a […]

Neurovalens Achieves FDA Clearance for Anxiety Treatment Device Read More »

Synchron Advances Toward Large-Scale Brain Implant Trials, Emerging as a Challenger to Neuralink

Synchron Readies for Large-Scale Brain Implant Trials, Posing Challenge to Neuralink

Synchron Gears Up for Large-Scale Brain Implant Trials, Challenging Neuralink Synchron Inc., backed by investors including Jeff Bezos and Bill Gates, is poised to challenge Elon Musk’s Neuralink with its innovative brain implant technology. The company, based in New York, is preparing to recruit patients for a pivotal clinical trial aimed at securing commercial approval

Synchron Readies for Large-Scale Brain Implant Trials, Posing Challenge to Neuralink Read More »

Neurable Inc. and Healthspan Digital Inc. Announce Partnership to Empower Precision Health and Longevity Clinics with Brain-Computer Interface Technologies

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics Neurable Inc., a leader in brain-computer interface (BCI) technology, and Healthspan Digital Inc., a Canadian HealthTech company specializing in precision health and longevity solutions, have announced a strategic partnership. The collaboration aims to commercialize Neurable’s advanced brain health tools and empower precision health and

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics Read More »

FDA FINDS PROBLEMS AT ANIMAL LAB RUN BY MUSK’S BRAIN IMPLANT COMPANY

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments Recent reports have surfaced alarming concerns about Neuralink’s quality control practices, prompting FDA scrutiny. Inspections at Neuralink’s California facility revealed troubling lapses in record-keeping and quality controls. These findings raise questions about the reliability of Neuralink’s experimental data and its readiness for human trials,

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments Read More »